Modeling the effect of energy status on mammary gland growth and lactation

The impact of nutrition on lactation can be separated into acute effects, affecting day-to-day yield, and chronic effects, which govern the persistency of lactation and rate of decline of the lactation curve. A mathematical model of the mammary gland was constructed to investigate both acute and chronic effects. Mammary growth is expressed in terms of the dynamics of populations of active (secreting) and quiescent (engorged) alveoli. The secretion rate of active alveoli is expressed in terms of the energy status of the dam. The model was fitted to data from a 2 x 2 factorial trial in which lactation curves were measured for heifers of two different genotypes (North American and New Zealand Holstein-Friesians) fed two different diets [grass and total mixed rations (TMR)]. Total formation of alveoli during pregnancy and lactation was statistically the same across all groups despite differences between diets, in the rate of formation of alveoli at parturition. The senescence rate of alveoli was significantly higher for heifers fed grass compared with heifers fed TMR, which corresponds to better persistency for heifers fed TMR. Heifers fed TMR had a higher rate of reactivation of quiescent alveoli than heifers fed grass, which also contributes to increased persistence for heifers fed TMR. There was a genotype x diet interaction in the rate of quiescence of active alveoli: the North American-Grass group had a higher rate of quiescence than the other three groups, perhaps reflecting differences in selection pressures between the New Zealand and North American genotypes.     

Modeling the interaction of milking frequency and nutrition on mammary gland growth and lactation

A mathematical model of biological mechanisms regulating lactation is constructed. In particular, the model allows prediction of the effect of milking frequency on milk yield and mammary regression, and the interaction of nutrition and milking frequency in determining yield. Possible interactions of nutrition with milking frequency on alveolar dynamics are highlighted. The model is based upon the association of prolonged engorgement (as a consequence of milk accumulation) of active secretory alveoli with changes in gene expression that result in impairment and, ultimately, cessation of milk secretion. The emptying of alveoli at milking, following alveolar contraction induced by oxytocin, prevents this process and also allows quiescent alveoli to reactivate. Prolonged engorgement results in apoptosis of the secretory cells and, hence, regression of the mammary gland. Milk yield is linked to alveolar populations, with secretion rates being modulated by nutrition and udder fill effects. The model was used to investigate different management scenarios, and is in agreement with experimental results. The model shows that while milking frequency drives alveolar population, and therefore potential milk production, actual production varies considerably with nutrition. A significant portion of the loss associated with once-daily milking was due to udder fill rather than loss of secretory tissue. The model showed qualitative agreement with experimental data, on the acute and chronic effects of temporary once-daily milking.     

Milk yield and mammary growth effects due to increased milking frequency during early lactation

Increased milking frequency (IMF) at the beginning of lactation has been shown to increase milk yield not only during IMF but also after its cessation. The objectives of this experiment evaluated the effects of increased milking frequency initiated during early lactation on mammary growth and effects on milk yield (MY). Thirty-one cows were divided into treatment groups: 1) 2X: cows milked twice daily (2X) beginning at parturition (d 1), 2) IMF1: cows milked four times daily (4X) from d 1 to 21 postpartum (PP) and 3) IMF4: cows milked 2X d 1 to 3 and 4X d 4 to 21 PP. The 4X cows were milked immediately before 2X cows and again approximately 3 h later, at the end of the normal milking routine. All cows were milked 2X from d 21 to 305 postpartum. Milk yields were 34.5, 37.8 and 37.6 kg/d during wk 1 to 44 for 2X, IMF1 and IMF4, respectively. Mammary biopsies from four cows per treatment were obtained on d 7 and 14 PP to evaluate mammary cell proliferation. Tritiated-thymidine incorporation tended to increase on d 7 in IMF1 cows, and arithmetic means of the percentage of cells expressing Ki-67 proliferation antigen were consistent with a proliferative response to IMF though not significant. Blood was sampled three times per wk during the first 2 wk and then once per wk during wk 3, 4, 5, 6, 8, and 10. Plasma insulin-like growth factor-1 (IGF-1) averaged 20.1 ng/ml in IMF cows vs. 24.2 in 2X but was not accompanied by a change in bST. Prolactin was also not affected by treatment. Neither milk yield nor potential effects on mammary cell proliferation were correlated with systemic IGF-1. Implementing an IMF routine increases MY during treatment and elicits a carryover effect on the remainder of lactation. Milk yield responses after an IMF routine may be the result of increased mammary cell proliferation.     

Cardiovascular responses and mammary substrate uptake in Jersey cows treated with pituitary-derived growth hormone during late lactation

Pituitary-derived bovine growth hormone (bGH) was administered to Jersey cows during late lactation for 7 d. Milk yield increased significantly during treatment and by a maximum of 49.6% on d 7. The magnitude of the increase was similar to that of mammary plasma flow (47.8 +/- 18.3%) over the same period. By 15-21 d after treatment, both variables had returned to pretreatment values. With respect to milk composition, bGH had negligible effect on lactose and fat concentrations but there were significant decreases in protein, sodium and chloride. Arterial plasma concentrations of bGH increased substantially during treatment, but the associated rise in insulin was not statistically significant. Haematocrit decreased significantly, the lowest value being recorded 3 d after bGH treatment ceased. Mammary respiratory quotient fell progressively after the start of bGH treatment and reached the lowest recorded value 3 d after treatment ceased (62.2 +/- 7.3% of pretreatment value). Glucose and acetate uptake by the mammary gland increased significantly during treatment, increase in glucose uptake being due both to a greater arterio-venous difference and to mammary plasma flow. There was strong evidence that the acute response in increased milk yield was associated with multiple effects in terms of mammary plasma flow and metabolism, as well as haematocrit changes indicative of increased plasma volume.     

Activity of lysosomal enzymes in murine mammary tissue through pregnancy, lactation, and involution

Murine mammary tissue homogenates obtained during pregnancy, lactation, and involution were assayed for activities of two lysosomal marker enzymes, acid phosphatase, and N-acetyl-beta-D-glucosaminidase. Acid phosphatase activity per milligram protein was relatively constant through pregnancy and lactation, although a decrease was detected at parturition. Acid phosphatase activity per milligram deoxyribonucleic acid was also stable through pregnancy and lactation except for a peak of activity during lactogenesis. Acid phosphatase activity per gram wet weight also remained stable during pregnancy and lactation, but activity was significantly higher during lactation than pregnancy. Glucosaminidase activity, whether expressed as milligrams deoxyribonucleic acid of milligrams protein, tended to decrease during pregnancy, decreased further with lactogenesis, and remained significantly lower throughout lactation. Glucosaminidase activity per gram wet weight increased as pregnancy progressed and slowly decreased through lactogenesis to midpregnancy levels, which remained stable throughout the remainder of lactation. Both acid phosphatase and glucosaminidase activities were slightly higher at the end of lactation, and both decreased within 24 h of weaning. Significant increases in activities of both enzymes were observed from d 1 to 4 of involution.     

Effect of dietary protein level during pregnancy and 2 weeks of lactation on mammary gland growth in rats

In a previous paper (Pyska & Styczyński, 1979) it was shown that protein level in the diet of a rat influences the development of its mammary gland during the animal's growth to sexual maturity. Rats fed a semi-synthetic diet containing 15% protein had better-developed mammary glands than rats on a diet containing 10% protein. The aim of the study now reported was to investigate the effect of the protein level in the diet on the development of the mammary gland during pregnancy and 14 d of lactation.     

Technical note: Therapeutic cessation of lactation of Staphylococcus aureus-infected mammary quarters

The objective of the present study was to compare the ability of chlorhexidine and povidone-iodine to cause cessation of lactation in Staphylococcus aureus-infected mammary quarters, assess milk production in the treated quarter in the subsequent lactation, and evaluate whether microbiological cure was obtained. Fourteen mid- to late-lactation Holstein-Friesian dairy cattle from the Washington State University dairy herd with single mammary quarter S. aureus intramammary infections were studied. Cows were randomly assigned to one of two treatment groups, povidone-iodine or chlorhexidine. Cows in the povidone-iodine group were infused with 120 ml of 5% povidone-iodine solution (0.5% iodine) after complete milk-out. Chlorhexidine-treated cows were infused with a proprietary chlorhexidine suspension after two milkings 24 h apart. Treated mammary quarters were not milked for the rest of the lactation. Milk production from each mammary quarter (kg of milk/quarter) was measured using in-line volume flow meters for 5 consecutive days before treatment and again at the start of the subsequent lactation. Povidoneiodine caused permanent cessation of lactation in the treated quarter, whereas 71% of the chlorhexidine-treated mammary quarters returned to function in the subsequent lactation. Hence, if the primary objective is to eliminate the mammary quarter from lactation, and thereby presumably lower the risk of herdmates acquiring new S. aureus intramammary infection, then povidone-iodine appears to be the best of the two methods. No difference in total milk production between lactation one and two in either group was found, suggesting that permanent loss of a quarter was not detrimental to overall milk production.     

In vitro growth of enterococci of bovine origin in bovine mammary secretions from various stages of lactation

In vitro growth responses of Enterococcus faecium and Enterococcus faecalis were tested in cell-free, fat-free bovine mammary secretions. Mammary secretions were collected during the dry period, and during early, late, and extended lactation. Sixty-three enterococcal isolates from aseptically collected bovine quarter milk samples and bedding samples from a commercial dairy herd were tested. Isolates from bovine quarter milk samples originated from mammary glands with clinical mastitis, cows with composite somatic cell score >4, postpartum milk samples, or from routine milk samples submitted to a mastitis diagnostic laboratory. Source of enterococcal isolates and the species significantly contribute to the ability of organisms to multiply in mammary secretions from various stages of lactation. Isolates collected from milk samples of the commercial herd and isolates from milk submitted to a mastitis diagnostic lab did not display enhanced growth in mammary secretions compared with isolates from bedding. Growth responses of E. faecalis were greater than those for E. faecium in secretions collected during the dry period, late lactation, and extended lactation. Bacterial growth did not differ between enterococcal species in mammary secretion collected from cows in early lactation. Differences in bacterial growth between E. faecalis and E. faecium in mammary secretions may indicate differences between species in susceptibility of mammary glands during the lactation cycle.     

Growth hormone-releasing factor effects on pituitary function, growth, and lactation

Growth and lactation are complex processes controlled by several metabolic hormones such as insulin, glucagon, and thyroid hormones but most notably growth hormone. Growth hormone secretion is regulated by two hypothalamic hormones, somatostatin, an inhibitory regulatory factor, and growth hormone-releasing factor. The quantity and pattern of growth hormone secretion is ultimately regulated in concert by the secretion of both regulatory factors from the hypothalamus through the hypothalamo-hypophyseal portal system, where they exert their actions at unique pituitary receptors. Because the potential use of exogenous growth hormone administration for the stimulation of growth efficiency and lactation has been demonstrated, recent efforts have been directed toward the enhancement of production through manipulation of endogenous growth hormone secretion via its releasing factor. Thus far, releasing factor-stimulated growth and lactation has not been achieved to the same extent as that of exogenous growth hormone. Growth hormone-releasing factor has stimulated growth in two growth hormone-deficient children, as well as female, but not male, rats. Although all food-producing species tested to date respond to growth hormone-releasing factor with the appropriate growth hormone response, continuous or pulsatile administration of releasing factor has not resulted in increased growth rate in sheep, chicks, or hogs. Despite levels of circulating growth hormone that would be expected to produce a 30% increase in milk production if given exogenously to dairy cows, releasing factor-stimulated growth hormone secretion has resulted in only a 3 to 9% increase. It is clear from these studies that further developments are necessary to demonstrate the practical application of growth hormone-releasing factor.     

Bovine somatotropin administration to dairy goats in late lactation: effects on mammary gland function,composition and morphology

We investigated the effects of bovine somatotropin (bST) on mammary gland function and composition in the declining phase of lactation in goats. Sixteen Saanen goats, 180 +/- 11 days in milk (DIM), were divided equally into control and treated groups. The treated group received 120 mg/2 wk of slow-release bST for three cycles. Milk yield, milk composition, milk clotting measures, and plasmin-plasminogen activator activities were recorded weekly. Milk Na and K were determined in individual milk samples collected weekly during the third cycle. Blood samples were collected weekly during the second cycle and the plasma analyzed for nonesterified fatty acids (NEFA), glucose, and urea. At the end of the 6 wk, three goats from each group were slaughtered, and the udders were removed. Mammary gland weight, composition, and total DNA content were determined. The histological effects of bST on mammary tissue were investigated. The analyzed parameters included numbers of alveoli, corpora amylacea, apoptotic cells, and laminin fibronectin distribution and localization. An extensive morphological analysis on the epithelial and stromal components was performed. Milk yield was significantly higher in the treated group, fat content was not affected, but protein and nonprotein nitrogen were lower in treated goats milk. Treatment with bST did not influence milk pH but reduced coagulation time. Plasmin and plasminogen activator activities were not affected. Milk K levels were higher and the Na/K ratio was lower in treated animals. Plasma glucose, NEFA, and urea were unaffected. Mammary gland weight and total DNA were higher in treated than control animals, suggesting that with advancing lactation bST treatment maintains cells. Fat, protein, and collagen content of the mammary tissue did not differ between the groups. Treatment with bST significantly increased the number of lactating alveoli (LA) and significantly reduced the number of regressing alveoli (RA) and corpora amylacea, both within and outside the alveolar lumen. Laminin and fibronectin localization were not affected, and very few apoptotic cells were found in both treated and control samples. Our findings suggest that bST administration to dairy goats in late lactation can modulate mammary gland activity and improve lactation persistency; this is associated with maintained total mammary parenchyma weight and lactating alveoli.